glp 1 heart muscle GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Incretin hormones—glucagon-like peptide-1 (GLP-1) and

Back Whyte, M (15 Nov 2023) 'Mounjaro has been authorised for weight loss in the UK here's how it compares to Wegovy', The Conversation

For optimal GH response: Morning (fasted): Mimics natural morning GH surge Post-workout: Enhances recovery and IGF-1 response Before bed: Aligns with deep sleep GH release Avoid taking it immediately after meals, as insulin blunts GH secretion

In summary, GLP-1 RAs represent a promising therapeutic option for obese patients with HFpEF, but their large-scale adoption will require further evidence of efficacy, safety, and long-term benefits through rigorous and well-designed clinical trials

Rising diabetes and obesity prevalence, strong clinical outcomes, patient awareness, insurance coverage, and demand for effective, convenient metabolic therapies drive growth

Until recently, the main obstacle was a needle

That is not changing any time soon